Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove

Assessing Genomic Alteration in Non-Squamous Non-Small Cell Lung Cancer Patients

September 8th, 2023
1,2,3,4,5, 1,2,3,4, 1,2,3,4, 1,2,3,4, 1,2,3,4, 1,2,3,4, 1,2,3,4, 1,2,3,4, 3,4,5,6, 3,4,5,6, 1,2,3,4,5, 1,2,3,4,5, 1,2,3,4,5
1Laboratory of Clinical and Experimental Pathology, Centre Hospitalier Universitaire de Nice, Université Côte d’Azur, CHU de Nice, 2Hospital-Integrated Biobank (BB-0033-00025), Université Côte d'Azur, Hôpital Pasteur, CHU de Nice, 3Institut Hospitalo-Universitaire (IHU), RespirERA, Université Côte d'Azur, Hôpital Pasteur, CHU de Nice, 4FHU OncoAge, Université Côte d'Azur, 5Team 4, Institute of Research on Cancer and Aging (IRCAN), CNRS INSERM, Centre Antoine-Lacassagne, Université Côte d'Azur, 6Department of Pulmonary Medicine and Thoracic Oncology, Centre Hospitalier Universitaire de Nice, Université Côte d'Azur

Summary
Automatic Translation

Økningen av molekylære biomarkører som skal testes for ikke-plateepitel ikke-småcellet lungekreft (NS-NSCLC) omsorgsstyring har ført til utvikling av raske og pålitelige molekylære deteksjonsmetoder. Vi beskriver en arbeidsflyt for genomisk endringsvurdering for NS-NSCLC-pasienter ved hjelp av en ultra-rask-neste generasjons sekvensering (NGS) tilnærming.

Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter